Work

Correction: Simbulan-Rosenthal et al. Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells. Int. J. Mol. Sci. 2022, 23, 2333

Year: 2026

Type: erratum

Abstract: In the original publication [...].

Source: International Journal of Molecular Sciences

DOI: 10.3390/ijms27177643

Authors: Cynthia M. Simbulan-Rosenthal, Yogameenakshi Haribabu, Sahar Vakili, Li-Wei Kuo, Havens Clark, Ryan Dougherty, Ryyan Alobaidi, Bonnie Carney, Peter Sykora, Dean S. Rosenthal

Institutions: Georgetown University, MedStar Health Research Institute

Language: English

Topic: CRISPR and Genetic Engineering

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,499

Funders: National Institute of General Medical Sciences, National Institute of Environmental Health Sciences

Awards: G1202554347, G2631575515, G5644609224

OpenAlex ID: W7204270388

Cites: 2

Cited by:

Related to: